TEON Trademark

Trademark Overview


On Thursday, October 4, 2018, a trademark application was filed for TEON with the United States Patent and Trademark Office. The USPTO has given the TEON trademark a serial number of 88143108. The federal status of this trademark filing is REGISTERED as of Tuesday, April 5, 2022. This trademark is owned by Teon Therapeutics, Inc.. The TEON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeleta...

Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, onc...
teon

General Information


Serial Number88143108
Word MarkTEON
Filing DateThursday, October 4, 2018
Status700 - REGISTERED
Status DateTuesday, April 5, 2022
Registration Number6694535
Registration DateTuesday, April 5, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics, namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 13, 2018
Primary Code005
First Use Anywhere DateFriday, February 18, 2022
First Use In Commerce DateFriday, February 18, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 13, 2018
Primary Code042
First Use Anywhere DateFriday, February 18, 2022
First Use In Commerce DateFriday, February 18, 2022

Trademark Owner History


Party NameTeon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Party NameTeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Party NameTeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, February 26, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 25, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, February 18, 2022USE AMENDMENT FILED
Friday, February 18, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, October 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 22, 2021EXTENSION 5 GRANTED
Thursday, October 14, 2021EXTENSION 5 FILED
Friday, October 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 14, 2021TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 16, 2021EXTENSION 4 GRANTED
Friday, April 16, 2021EXTENSION 4 FILED
Friday, April 16, 2021TEAS EXTENSION RECEIVED
Monday, April 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 24, 2020EXTENSION 3 GRANTED
Thursday, September 24, 2020EXTENSION 3 FILED
Thursday, September 24, 2020TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020EXTENSION 2 GRANTED
Monday, April 20, 2020EXTENSION 2 FILED
Monday, April 20, 2020TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2019EXTENSION 1 GRANTED
Friday, September 27, 2019EXTENSION 1 FILED
Friday, September 27, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 16, 2019ASSIGNED TO EXAMINER
Saturday, October 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 8, 2018NEW APPLICATION ENTERED IN TRAM